US 7959923
Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 7959923 (Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA) held by The Regents of the University of California expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P